{"324711":{"#nid":"324711","#data":{"type":"news","title":"BME PROFESSOR LEADS CLINICAL TRIAL FOR CANCER-DETECTING TOOL","body":[{"value":"\u003Cp\u003EA BME professor recently discovered how to use tiny glowing particles to detect malignant cancer cells. And he\u0027s turning his groundbreaking cancer-detection technology into a commercial venture.\u003C\/p\u003E\u003Cp\u003E\u201cOne of the biggest challenges with surgeries to remove tumors is that there are residual cancer cells left behind. They account for about 40 percent of cancer recurrence,\u201d said Shuming Nie, Ph.D., a Wallace H. Coulter Distinguished Faculty Chair and director of the Emory-Georgia Tech Cancer Nanotechnology Center. \u201cOur technology uses tiny luminescent particles that bond to these cancerous cells to show doctors where the malignant cells remain so they can be removed.\u201d\u003C\/p\u003E\u003Cp\u003ENie hopes to commercialize the technology by early 2015, likely starting in Europe where the regulatory process moves faster. Nie will work in tandem with the biomedical technology company Spectropath, a spinoff founded by one of his former students.\u003C\/p\u003E\u003Cp\u003ESpectropath was started in 2009 to further develop and commercializing image-guided cancer surgery.\u003C\/p\u003E\u003Cp\u003EThe venture recently received a boost from the National Institutes of Health, which awarded Nie and his team a five-year, $6.9 million transformative research award.\u003C\/p\u003E\u003Cp\u003E\u201cThis award supports projects that are high-risk, high-payoff,\u201d Nie said. \u201cIn other words, we may face major challenges, but we also have the potential to make an enormous impact on the field of medicine. This technology will literally save lives.\u201d\u003C\/p\u003E\u003Cp\u003EThe technology has a host of practical applications where it may prove useful. It could allow for minimally invasive pathology via fiber optics, as opposed to the generally random sampling currently used in biopsies. Scientists are already researching how it might help combat cardiovascular disease, using the same ultra-small glowing particles to target plaque in the arteries. It may have implications for cell-based therapy and regenerative medicine as well.\u003C\/p\u003E\u003Cp\u003E\u201cBiomedical engineering is a field that allows you to turn your personal interests and curiosities into practical applications for human health,\u201d Nie said. \u0022It\u2019s a most satisfying field.\u201d\u003C\/p\u003E\u003Cp\u003EClinical trials on the new technology are expected to begin in Europe early next year.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u0026nbsp;\u003C\/strong\u003E\u003Cstrong\u003ERelated Links:\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=40\u0022 target=\u0022_blank\u0022\u003EShuming Nie\u2019s Profile\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/scholar.google.com\/citations?user=8_C-MpAAAAAJ\u0026amp;hl=en\u0022 target=\u0022_blank\u0022\u003EGoogle Scholar\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.emoryhealthsciblog.com\/pilot-human-trial-image-guided-cancer-surgery-tool\/#more-8562\u0022 target=\u0022_blank\u0022\u003EEmory Press Release\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.vet.upenn.edu\/about\/news-and-events\/press-releases\/article\/penn-team-makes-cancer-glow-to-improve-surgical-outcomes\u0022 target=\u0022_blank\u0022\u003EUPenn News Release\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.atlantamagazine.com\/health\/healthcare-champions\u0022 target=\u0022_self\u0022\u003EAtlanta Magazine Article\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Cp\u003EWritten by Chris Calleri\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":"","field_summary_sentence":[{"value":"A BME professor recently discovered how to use tiny glowing particles to detect malignant cancer cells."}],"uid":"27960","created_gmt":"2014-09-15 06:27:26","changed_gmt":"2016-10-08 03:17:04","author":"Chris Calleri","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2014-09-15T00:00:00-04:00","iso_date":"2014-09-15T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"324681":{"id":"324681","type":"image","title":"Shuming Nie 1","body":null,"created":"1449245025","gmt_created":"2015-12-04 16:03:45","changed":"1475895034","gmt_changed":"2016-10-08 02:50:34","alt":"Shuming Nie 1","file":{"fid":"200190","name":"screen_shot_2014-09-15_at_6.22.56_am.png","image_path":"\/sites\/default\/files\/images\/screen_shot_2014-09-15_at_6.22.56_am_0.png","image_full_path":"http:\/\/tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/screen_shot_2014-09-15_at_6.22.56_am_0.png","mime":"image\/png","size":800324,"path_740":"http:\/\/tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/screen_shot_2014-09-15_at_6.22.56_am_0.png?itok=u3CkLRbI"}},"324691":{"id":"324691","type":"image","title":"Shuming Nie 2","body":null,"created":"1449245025","gmt_created":"2015-12-04 16:03:45","changed":"1475895034","gmt_changed":"2016-10-08 02:50:34","alt":"Shuming Nie 2","file":{"fid":"200191","name":"screen_shot_2014-09-15_at_6.24.18_am.png","image_path":"\/sites\/default\/files\/images\/screen_shot_2014-09-15_at_6.24.18_am_0.png","image_full_path":"http:\/\/tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/screen_shot_2014-09-15_at_6.24.18_am_0.png","mime":"image\/png","size":761809,"path_740":"http:\/\/tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/screen_shot_2014-09-15_at_6.24.18_am_0.png?itok=wteZJjBE"}},"324701":{"id":"324701","type":"image","title":"Shuming Nie 3","body":null,"created":"1449245025","gmt_created":"2015-12-04 16:03:45","changed":"1475895034","gmt_changed":"2016-10-08 02:50:34","alt":"Shuming Nie 3","file":{"fid":"200192","name":"screen_shot_2014-09-15_at_6.24.39_am.png","image_path":"\/sites\/default\/files\/images\/screen_shot_2014-09-15_at_6.24.39_am_0.png","image_full_path":"http:\/\/tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/screen_shot_2014-09-15_at_6.24.39_am_0.png","mime":"image\/png","size":736034,"path_740":"http:\/\/tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/screen_shot_2014-09-15_at_6.24.39_am_0.png?itok=rlmyD6Sb"}}},"media_ids":["324681","324691","324701"],"groups":[{"id":"1254","name":"Wallace H. Coulter Dept. of Biomedical Engineering"}],"categories":[{"id":"139","name":"Business"},{"id":"42941","name":"Art Research"},{"id":"140","name":"Cancer Research"}],"keywords":[{"id":"1612","name":"BME"},{"id":"1072","name":"Business"},{"id":"385","name":"cancer"},{"id":"364","name":"Funding"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EChris Calleri\u003Cbr \/\u003E Communications Manager\u003Cbr \/\u003E Wallace H. Coulter Department of Biomedical Engineering\u003Cbr \/\u003E Georgia Institute of Technology \u0026amp; Emory School of Medicine\u003Cbr \/\u003E 313 Ferst Drive, Suite 2120\u003Cbr \/\u003E Atlanta, GA \u0026nbsp;30332-0535\u003Cbr \/\u003E Phone: \u0026nbsp;404.385.2416\u003C\/p\u003E","format":"limited_html"}],"email":["chris.calleri@bme.gatech.edu"],"slides":[],"orientation":[],"userdata":""}}}